nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—restless legs syndrome—Clonidine—glaucoma	0.459	1	CpDpCtD
L-DOPA—Epinephrine—Dipivefrin—glaucoma	0.291	1	CrCrCtD
L-DOPA—CYP2D6—Carteolol—glaucoma	0.0219	0.334	CbGbCtD
L-DOPA—CYP2D6—Betaxolol—glaucoma	0.0148	0.226	CbGbCtD
L-DOPA—CYP2D6—Methazolamide—glaucoma	0.0112	0.171	CbGbCtD
L-DOPA—CYP2D6—Timolol—glaucoma	0.00951	0.145	CbGbCtD
L-DOPA—DRD5—eyelid—glaucoma	0.00866	0.404	CbGeAlD
L-DOPA—CYP2D6—Clonidine—glaucoma	0.00809	0.124	CbGbCtD
L-DOPA—SLC7A8—optic choroid—glaucoma	0.00576	0.269	CbGeAlD
L-DOPA—PSIP1—eye—glaucoma	0.00176	0.082	CbGeAlD
L-DOPA—PSIP1—retina—glaucoma	0.00174	0.0813	CbGeAlD
L-DOPA—SLC7A5—eye—glaucoma	0.000898	0.0419	CbGeAlD
L-DOPA—SLC7A5—retina—glaucoma	0.00089	0.0415	CbGeAlD
L-DOPA—SLC7A5—connective tissue—glaucoma	0.000865	0.0404	CbGeAlD
L-DOPA—DRD2—eye—glaucoma	0.000435	0.0203	CbGeAlD
L-DOPA—DRD2—retina—glaucoma	0.000431	0.0201	CbGeAlD
L-DOPA—Aminosalicylic Acid—PTGS2—glaucoma	0.000125	0.366	CrCbGaD
L-DOPA—Epinephrine—TNF—glaucoma	0.000119	0.348	CrCbGaD
L-DOPA—Upper respiratory tract infection—Timolol—glaucoma	0.000109	0.000835	CcSEcCtD
L-DOPA—Dyspnoea—Brinzolamide—glaucoma	0.000109	0.000835	CcSEcCtD
L-DOPA—Dyspepsia—Travoprost—glaucoma	0.000109	0.000835	CcSEcCtD
L-DOPA—Asthenia—Apraclonidine—glaucoma	0.000109	0.000833	CcSEcCtD
L-DOPA—Somnolence—Brinzolamide—glaucoma	0.000109	0.000832	CcSEcCtD
L-DOPA—Vision blurred—Clonidine—glaucoma	0.000108	0.00083	CcSEcCtD
L-DOPA—Decreased appetite—Dorzolamide—glaucoma	0.000108	0.000828	CcSEcCtD
L-DOPA—Urticaria—Acetazolamide—glaucoma	0.000108	0.000825	CcSEcCtD
L-DOPA—Tremor—Clonidine—glaucoma	0.000108	0.000825	CcSEcCtD
L-DOPA—Dyspepsia—Brinzolamide—glaucoma	0.000107	0.000824	CcSEcCtD
L-DOPA—Pruritus—Apraclonidine—glaucoma	0.000107	0.000822	CcSEcCtD
L-DOPA—Fatigue—Dorzolamide—glaucoma	0.000107	0.000821	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Travoprost—glaucoma	0.000107	0.000819	CcSEcCtD
L-DOPA—Fatigue—Travoprost—glaucoma	0.000107	0.000818	CcSEcCtD
L-DOPA—Flushing—Betaxolol—glaucoma	0.000107	0.000817	CcSEcCtD
L-DOPA—Ill-defined disorder—Clonidine—glaucoma	0.000107	0.000817	CcSEcCtD
L-DOPA—Pain—Dorzolamide—glaucoma	0.000106	0.000814	CcSEcCtD
L-DOPA—Insomnia—Pilocarpine—glaucoma	0.000106	0.000814	CcSEcCtD
L-DOPA—Decreased appetite—Brinzolamide—glaucoma	0.000106	0.000814	CcSEcCtD
L-DOPA—Weight decreased—Timolol—glaucoma	0.000106	0.000813	CcSEcCtD
L-DOPA—Constipation—Travoprost—glaucoma	0.000106	0.000811	CcSEcCtD
L-DOPA—Pain—Travoprost—glaucoma	0.000106	0.000811	CcSEcCtD
L-DOPA—Agitation—Clonidine—glaucoma	0.000106	0.000809	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000105	0.000808	CcSEcCtD
L-DOPA—Paraesthesia—Pilocarpine—glaucoma	0.000105	0.000808	CcSEcCtD
L-DOPA—Asthenia—Bimatoprost—glaucoma	0.000105	0.000808	CcSEcCtD
L-DOPA—Fatigue—Brinzolamide—glaucoma	0.000105	0.000807	CcSEcCtD
L-DOPA—Angioedema—Clonidine—glaucoma	0.000105	0.000805	CcSEcCtD
L-DOPA—Dyspnoea—Pilocarpine—glaucoma	0.000105	0.000802	CcSEcCtD
L-DOPA—Pain—Brinzolamide—glaucoma	0.000104	0.000801	CcSEcCtD
L-DOPA—Somnolence—Pilocarpine—glaucoma	0.000104	0.0008	CcSEcCtD
L-DOPA—Depression—Timolol—glaucoma	0.000104	0.000799	CcSEcCtD
L-DOPA—Pruritus—Bimatoprost—glaucoma	0.000104	0.000797	CcSEcCtD
L-DOPA—Diarrhoea—Apraclonidine—glaucoma	0.000104	0.000795	CcSEcCtD
L-DOPA—Malaise—Clonidine—glaucoma	0.000104	0.000794	CcSEcCtD
L-DOPA—Dyspepsia—Pilocarpine—glaucoma	0.000103	0.000792	CcSEcCtD
L-DOPA—Syncope—Clonidine—glaucoma	0.000103	0.00079	CcSEcCtD
L-DOPA—Arrhythmia—Betaxolol—glaucoma	0.000103	0.000787	CcSEcCtD
L-DOPA—Feeling abnormal—Dorzolamide—glaucoma	0.000102	0.000785	CcSEcCtD
L-DOPA—Decreased appetite—Pilocarpine—glaucoma	0.000102	0.000782	CcSEcCtD
L-DOPA—Feeling abnormal—Travoprost—glaucoma	0.000102	0.000781	CcSEcCtD
L-DOPA—Gastrointestinal pain—Dorzolamide—glaucoma	0.000102	0.000779	CcSEcCtD
L-DOPA—Alopecia—Betaxolol—glaucoma	0.000101	0.000778	CcSEcCtD
L-DOPA—Palpitations—Clonidine—glaucoma	0.000101	0.000778	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000101	0.000777	CcSEcCtD
L-DOPA—Gastrointestinal pain—Travoprost—glaucoma	0.000101	0.000775	CcSEcCtD
L-DOPA—Loss of consciousness—Clonidine—glaucoma	0.000101	0.000774	CcSEcCtD
L-DOPA—Feeling abnormal—Brinzolamide—glaucoma	0.000101	0.000772	CcSEcCtD
L-DOPA—Mental disorder—Betaxolol—glaucoma	0.000101	0.000772	CcSEcCtD
L-DOPA—Constipation—Pilocarpine—glaucoma	0.0001	0.00077	CcSEcCtD
L-DOPA—Pain—Pilocarpine—glaucoma	0.0001	0.00077	CcSEcCtD
L-DOPA—Cough—Clonidine—glaucoma	0.0001	0.000768	CcSEcCtD
L-DOPA—Dizziness—Apraclonidine—glaucoma	0.0001	0.000768	CcSEcCtD
L-DOPA—Urticaria—Dorzolamide—glaucoma	9.87e-05	0.000757	CcSEcCtD
L-DOPA—Mesalazine—PTGS2—glaucoma	9.84e-05	0.287	CrCbGaD
L-DOPA—Abdominal pain—Dorzolamide—glaucoma	9.82e-05	0.000753	CcSEcCtD
L-DOPA—Tension—Betaxolol—glaucoma	9.81e-05	0.000752	CcSEcCtD
L-DOPA—Dysgeusia—Betaxolol—glaucoma	9.79e-05	0.000751	CcSEcCtD
L-DOPA—Chest pain—Clonidine—glaucoma	9.78e-05	0.00075	CcSEcCtD
L-DOPA—Abdominal pain—Travoprost—glaucoma	9.78e-05	0.00075	CcSEcCtD
L-DOPA—Agranulocytosis—Timolol—glaucoma	9.75e-05	0.000748	CcSEcCtD
L-DOPA—Anxiety—Clonidine—glaucoma	9.74e-05	0.000747	CcSEcCtD
L-DOPA—Asthenia—Acetazolamide—glaucoma	9.72e-05	0.000746	CcSEcCtD
L-DOPA—Dizziness—Bimatoprost—glaucoma	9.71e-05	0.000745	CcSEcCtD
L-DOPA—Nervousness—Betaxolol—glaucoma	9.71e-05	0.000745	CcSEcCtD
L-DOPA—Urticaria—Brinzolamide—glaucoma	9.7e-05	0.000744	CcSEcCtD
L-DOPA—Feeling abnormal—Pilocarpine—glaucoma	9.67e-05	0.000742	CcSEcCtD
L-DOPA—Discomfort—Clonidine—glaucoma	9.66e-05	0.000741	CcSEcCtD
L-DOPA—Vomiting—Apraclonidine—glaucoma	9.63e-05	0.000739	CcSEcCtD
L-DOPA—Muscle spasms—Betaxolol—glaucoma	9.61e-05	0.000737	CcSEcCtD
L-DOPA—Gastrointestinal pain—Pilocarpine—glaucoma	9.6e-05	0.000736	CcSEcCtD
L-DOPA—Hypersensitivity—Brimonidine—glaucoma	9.58e-05	0.000735	CcSEcCtD
L-DOPA—Dry mouth—Clonidine—glaucoma	9.56e-05	0.000733	CcSEcCtD
L-DOPA—Dermatitis—Apraclonidine—glaucoma	9.54e-05	0.000732	CcSEcCtD
L-DOPA—Headache—Apraclonidine—glaucoma	9.49e-05	0.000728	CcSEcCtD
L-DOPA—Confusional state—Clonidine—glaucoma	9.45e-05	0.000725	CcSEcCtD
L-DOPA—Vision blurred—Betaxolol—glaucoma	9.42e-05	0.000723	CcSEcCtD
L-DOPA—Rhinitis—Timolol—glaucoma	9.41e-05	0.000721	CcSEcCtD
L-DOPA—Oedema—Clonidine—glaucoma	9.37e-05	0.000719	CcSEcCtD
L-DOPA—Tremor—Betaxolol—glaucoma	9.37e-05	0.000718	CcSEcCtD
L-DOPA—Hallucination—Timolol—glaucoma	9.33e-05	0.000716	CcSEcCtD
L-DOPA—Asthenia—Brimonidine—glaucoma	9.33e-05	0.000716	CcSEcCtD
L-DOPA—Abdominal pain—Pilocarpine—glaucoma	9.28e-05	0.000711	CcSEcCtD
L-DOPA—Ill-defined disorder—Betaxolol—glaucoma	9.28e-05	0.000711	CcSEcCtD
L-DOPA—Diarrhoea—Acetazolamide—glaucoma	9.27e-05	0.000711	CcSEcCtD
L-DOPA—Rash—Bimatoprost—glaucoma	9.26e-05	0.00071	CcSEcCtD
L-DOPA—Dermatitis—Bimatoprost—glaucoma	9.25e-05	0.000709	CcSEcCtD
L-DOPA—Anaemia—Betaxolol—glaucoma	9.24e-05	0.000709	CcSEcCtD
L-DOPA—Shock—Clonidine—glaucoma	9.22e-05	0.000707	CcSEcCtD
L-DOPA—Pruritus—Brimonidine—glaucoma	9.2e-05	0.000706	CcSEcCtD
L-DOPA—Headache—Bimatoprost—glaucoma	9.2e-05	0.000706	CcSEcCtD
L-DOPA—Thrombocytopenia—Clonidine—glaucoma	9.18e-05	0.000704	CcSEcCtD
L-DOPA—Hypersensitivity—Dorzolamide—glaucoma	9.15e-05	0.000702	CcSEcCtD
L-DOPA—Hypersensitivity—Travoprost—glaucoma	9.11e-05	0.000699	CcSEcCtD
L-DOPA—Hyperhidrosis—Clonidine—glaucoma	9.06e-05	0.000695	CcSEcCtD
L-DOPA—Malaise—Betaxolol—glaucoma	9.02e-05	0.000691	CcSEcCtD
L-DOPA—Nausea—Apraclonidine—glaucoma	9e-05	0.00069	CcSEcCtD
L-DOPA—Hypersensitivity—Brinzolamide—glaucoma	9e-05	0.00069	CcSEcCtD
L-DOPA—Syncope—Betaxolol—glaucoma	8.96e-05	0.000688	CcSEcCtD
L-DOPA—Dizziness—Acetazolamide—glaucoma	8.96e-05	0.000687	CcSEcCtD
L-DOPA—Anorexia—Clonidine—glaucoma	8.93e-05	0.000685	CcSEcCtD
L-DOPA—Asthenia—Dorzolamide—glaucoma	8.91e-05	0.000683	CcSEcCtD
L-DOPA—Asthenia—Travoprost—glaucoma	8.87e-05	0.00068	CcSEcCtD
L-DOPA—Palpitations—Betaxolol—glaucoma	8.83e-05	0.000678	CcSEcCtD
L-DOPA—Pruritus—Dorzolamide—glaucoma	8.79e-05	0.000674	CcSEcCtD
L-DOPA—Loss of consciousness—Betaxolol—glaucoma	8.79e-05	0.000674	CcSEcCtD
L-DOPA—Asthenia—Brinzolamide—glaucoma	8.76e-05	0.000672	CcSEcCtD
L-DOPA—Hypotension—Clonidine—glaucoma	8.76e-05	0.000672	CcSEcCtD
L-DOPA—Pruritus—Travoprost—glaucoma	8.75e-05	0.000671	CcSEcCtD
L-DOPA—Cough—Betaxolol—glaucoma	8.72e-05	0.000669	CcSEcCtD
L-DOPA—Nausea—Bimatoprost—glaucoma	8.72e-05	0.000669	CcSEcCtD
L-DOPA—Hypersensitivity—Pilocarpine—glaucoma	8.65e-05	0.000663	CcSEcCtD
L-DOPA—Pruritus—Brinzolamide—glaucoma	8.64e-05	0.000662	CcSEcCtD
L-DOPA—Vomiting—Acetazolamide—glaucoma	8.61e-05	0.000661	CcSEcCtD
L-DOPA—Dizziness—Brimonidine—glaucoma	8.6e-05	0.000659	CcSEcCtD
L-DOPA—Chest pain—Betaxolol—glaucoma	8.51e-05	0.000653	CcSEcCtD
L-DOPA—Diarrhoea—Dorzolamide—glaucoma	8.5e-05	0.000652	CcSEcCtD
L-DOPA—Headache—Acetazolamide—glaucoma	8.49e-05	0.000651	CcSEcCtD
L-DOPA—Anxiety—Betaxolol—glaucoma	8.48e-05	0.00065	CcSEcCtD
L-DOPA—Insomnia—Clonidine—glaucoma	8.48e-05	0.00065	CcSEcCtD
L-DOPA—Diarrhoea—Travoprost—glaucoma	8.46e-05	0.000649	CcSEcCtD
L-DOPA—Asthenia—Pilocarpine—glaucoma	8.42e-05	0.000646	CcSEcCtD
L-DOPA—Paraesthesia—Clonidine—glaucoma	8.41e-05	0.000645	CcSEcCtD
L-DOPA—Discomfort—Betaxolol—glaucoma	8.41e-05	0.000645	CcSEcCtD
L-DOPA—Arrhythmia—Timolol—glaucoma	8.38e-05	0.000643	CcSEcCtD
L-DOPA—Dyspnoea—Clonidine—glaucoma	8.35e-05	0.000641	CcSEcCtD
L-DOPA—Diarrhoea—Brinzolamide—glaucoma	8.35e-05	0.000641	CcSEcCtD
L-DOPA—Somnolence—Clonidine—glaucoma	8.33e-05	0.000639	CcSEcCtD
L-DOPA—Dry mouth—Betaxolol—glaucoma	8.32e-05	0.000638	CcSEcCtD
L-DOPA—Pruritus—Pilocarpine—glaucoma	8.3e-05	0.000637	CcSEcCtD
L-DOPA—Alopecia—Timolol—glaucoma	8.29e-05	0.000636	CcSEcCtD
L-DOPA—Confusional state—Betaxolol—glaucoma	8.23e-05	0.000631	CcSEcCtD
L-DOPA—Mental disorder—Timolol—glaucoma	8.22e-05	0.00063	CcSEcCtD
L-DOPA—Dizziness—Dorzolamide—glaucoma	8.21e-05	0.00063	CcSEcCtD
L-DOPA—Rash—Brimonidine—glaucoma	8.2e-05	0.000629	CcSEcCtD
L-DOPA—Dermatitis—Brimonidine—glaucoma	8.19e-05	0.000628	CcSEcCtD
L-DOPA—Dizziness—Travoprost—glaucoma	8.18e-05	0.000627	CcSEcCtD
L-DOPA—Oedema—Betaxolol—glaucoma	8.16e-05	0.000626	CcSEcCtD
L-DOPA—Headache—Brimonidine—glaucoma	8.15e-05	0.000625	CcSEcCtD
L-DOPA—Decreased appetite—Clonidine—glaucoma	8.15e-05	0.000625	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Clonidine—glaucoma	8.09e-05	0.00062	CcSEcCtD
L-DOPA—Fatigue—Clonidine—glaucoma	8.08e-05	0.00062	CcSEcCtD
L-DOPA—Dizziness—Brinzolamide—glaucoma	8.07e-05	0.000619	CcSEcCtD
L-DOPA—Nausea—Acetazolamide—glaucoma	8.05e-05	0.000617	CcSEcCtD
L-DOPA—Diarrhoea—Pilocarpine—glaucoma	8.03e-05	0.000616	CcSEcCtD
L-DOPA—Shock—Betaxolol—glaucoma	8.03e-05	0.000616	CcSEcCtD
L-DOPA—Tension—Timolol—glaucoma	8.01e-05	0.000615	CcSEcCtD
L-DOPA—Pain—Clonidine—glaucoma	8.01e-05	0.000615	CcSEcCtD
L-DOPA—Constipation—Clonidine—glaucoma	8.01e-05	0.000615	CcSEcCtD
L-DOPA—Dysgeusia—Timolol—glaucoma	8e-05	0.000613	CcSEcCtD
L-DOPA—Thrombocytopenia—Betaxolol—glaucoma	7.99e-05	0.000613	CcSEcCtD
L-DOPA—Nervousness—Timolol—glaucoma	7.93e-05	0.000608	CcSEcCtD
L-DOPA—Vomiting—Dorzolamide—glaucoma	7.9e-05	0.000606	CcSEcCtD
L-DOPA—Hyperhidrosis—Betaxolol—glaucoma	7.89e-05	0.000605	CcSEcCtD
L-DOPA—Rash—Dorzolamide—glaucoma	7.83e-05	0.000601	CcSEcCtD
L-DOPA—Dermatitis—Dorzolamide—glaucoma	7.82e-05	0.0006	CcSEcCtD
L-DOPA—Rash—Travoprost—glaucoma	7.8e-05	0.000598	CcSEcCtD
L-DOPA—Dermatitis—Travoprost—glaucoma	7.79e-05	0.000597	CcSEcCtD
L-DOPA—Headache—Dorzolamide—glaucoma	7.78e-05	0.000597	CcSEcCtD
L-DOPA—Anorexia—Betaxolol—glaucoma	7.78e-05	0.000596	CcSEcCtD
L-DOPA—Vomiting—Brinzolamide—glaucoma	7.76e-05	0.000595	CcSEcCtD
L-DOPA—Dizziness—Pilocarpine—glaucoma	7.76e-05	0.000595	CcSEcCtD
L-DOPA—Headache—Travoprost—glaucoma	7.75e-05	0.000594	CcSEcCtD
L-DOPA—Nausea—Brimonidine—glaucoma	7.72e-05	0.000592	CcSEcCtD
L-DOPA—Feeling abnormal—Clonidine—glaucoma	7.72e-05	0.000592	CcSEcCtD
L-DOPA—Rash—Brinzolamide—glaucoma	7.7e-05	0.00059	CcSEcCtD
L-DOPA—Vision blurred—Timolol—glaucoma	7.7e-05	0.00059	CcSEcCtD
L-DOPA—Dermatitis—Brinzolamide—glaucoma	7.69e-05	0.00059	CcSEcCtD
L-DOPA—Gastrointestinal pain—Clonidine—glaucoma	7.66e-05	0.000588	CcSEcCtD
L-DOPA—Headache—Brinzolamide—glaucoma	7.65e-05	0.000587	CcSEcCtD
L-DOPA—Hypotension—Betaxolol—glaucoma	7.62e-05	0.000585	CcSEcCtD
L-DOPA—Angioedema—Timolol—glaucoma	7.46e-05	0.000572	CcSEcCtD
L-DOPA—Vomiting—Pilocarpine—glaucoma	7.46e-05	0.000572	CcSEcCtD
L-DOPA—Urticaria—Clonidine—glaucoma	7.44e-05	0.000571	CcSEcCtD
L-DOPA—Abdominal pain—Clonidine—glaucoma	7.41e-05	0.000568	CcSEcCtD
L-DOPA—Rash—Pilocarpine—glaucoma	7.4e-05	0.000567	CcSEcCtD
L-DOPA—Dermatitis—Pilocarpine—glaucoma	7.39e-05	0.000567	CcSEcCtD
L-DOPA—Insomnia—Betaxolol—glaucoma	7.38e-05	0.000566	CcSEcCtD
L-DOPA—Nausea—Dorzolamide—glaucoma	7.38e-05	0.000566	CcSEcCtD
L-DOPA—Headache—Pilocarpine—glaucoma	7.35e-05	0.000564	CcSEcCtD
L-DOPA—Nausea—Travoprost—glaucoma	7.34e-05	0.000563	CcSEcCtD
L-DOPA—Paraesthesia—Betaxolol—glaucoma	7.33e-05	0.000562	CcSEcCtD
L-DOPA—Syncope—Timolol—glaucoma	7.32e-05	0.000562	CcSEcCtD
L-DOPA—Dyspnoea—Betaxolol—glaucoma	7.27e-05	0.000558	CcSEcCtD
L-DOPA—Nausea—Brinzolamide—glaucoma	7.25e-05	0.000556	CcSEcCtD
L-DOPA—Palpitations—Timolol—glaucoma	7.22e-05	0.000553	CcSEcCtD
L-DOPA—Dyspepsia—Betaxolol—glaucoma	7.18e-05	0.000551	CcSEcCtD
L-DOPA—Loss of consciousness—Timolol—glaucoma	7.18e-05	0.00055	CcSEcCtD
L-DOPA—Cough—Timolol—glaucoma	7.13e-05	0.000547	CcSEcCtD
L-DOPA—Decreased appetite—Betaxolol—glaucoma	7.09e-05	0.000544	CcSEcCtD
L-DOPA—Hypertension—Timolol—glaucoma	7.05e-05	0.000541	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Betaxolol—glaucoma	7.04e-05	0.00054	CcSEcCtD
L-DOPA—Fatigue—Betaxolol—glaucoma	7.03e-05	0.000539	CcSEcCtD
L-DOPA—Pain—Betaxolol—glaucoma	6.98e-05	0.000535	CcSEcCtD
L-DOPA—Constipation—Betaxolol—glaucoma	6.98e-05	0.000535	CcSEcCtD
L-DOPA—Nausea—Pilocarpine—glaucoma	6.97e-05	0.000535	CcSEcCtD
L-DOPA—Chest pain—Timolol—glaucoma	6.95e-05	0.000533	CcSEcCtD
L-DOPA—Anxiety—Timolol—glaucoma	6.93e-05	0.000531	CcSEcCtD
L-DOPA—Hypersensitivity—Clonidine—glaucoma	6.9e-05	0.000529	CcSEcCtD
L-DOPA—Discomfort—Timolol—glaucoma	6.87e-05	0.000527	CcSEcCtD
L-DOPA—Dry mouth—Timolol—glaucoma	6.8e-05	0.000521	CcSEcCtD
L-DOPA—Asthenia—Clonidine—glaucoma	6.72e-05	0.000516	CcSEcCtD
L-DOPA—Feeling abnormal—Betaxolol—glaucoma	6.72e-05	0.000516	CcSEcCtD
L-DOPA—Confusional state—Timolol—glaucoma	6.72e-05	0.000515	CcSEcCtD
L-DOPA—Oedema—Timolol—glaucoma	6.67e-05	0.000511	CcSEcCtD
L-DOPA—Pruritus—Clonidine—glaucoma	6.63e-05	0.000508	CcSEcCtD
L-DOPA—Shock—Timolol—glaucoma	6.56e-05	0.000503	CcSEcCtD
L-DOPA—Urticaria—Betaxolol—glaucoma	6.48e-05	0.000497	CcSEcCtD
L-DOPA—Hyperhidrosis—Timolol—glaucoma	6.44e-05	0.000494	CcSEcCtD
L-DOPA—Diarrhoea—Clonidine—glaucoma	6.41e-05	0.000492	CcSEcCtD
L-DOPA—Anorexia—Timolol—glaucoma	6.35e-05	0.000487	CcSEcCtD
L-DOPA—Hypotension—Timolol—glaucoma	6.23e-05	0.000478	CcSEcCtD
L-DOPA—Dizziness—Clonidine—glaucoma	6.2e-05	0.000475	CcSEcCtD
L-DOPA—Insomnia—Timolol—glaucoma	6.03e-05	0.000462	CcSEcCtD
L-DOPA—Hypersensitivity—Betaxolol—glaucoma	6.01e-05	0.000461	CcSEcCtD
L-DOPA—Paraesthesia—Timolol—glaucoma	5.98e-05	0.000459	CcSEcCtD
L-DOPA—Vomiting—Clonidine—glaucoma	5.96e-05	0.000457	CcSEcCtD
L-DOPA—Dyspnoea—Timolol—glaucoma	5.94e-05	0.000456	CcSEcCtD
L-DOPA—Somnolence—Timolol—glaucoma	5.93e-05	0.000454	CcSEcCtD
L-DOPA—Rash—Clonidine—glaucoma	5.91e-05	0.000453	CcSEcCtD
L-DOPA—Dermatitis—Clonidine—glaucoma	5.9e-05	0.000453	CcSEcCtD
L-DOPA—Headache—Clonidine—glaucoma	5.87e-05	0.00045	CcSEcCtD
L-DOPA—Dyspepsia—Timolol—glaucoma	5.87e-05	0.00045	CcSEcCtD
L-DOPA—Asthenia—Betaxolol—glaucoma	5.85e-05	0.000449	CcSEcCtD
L-DOPA—Decreased appetite—Timolol—glaucoma	5.79e-05	0.000444	CcSEcCtD
L-DOPA—Pruritus—Betaxolol—glaucoma	5.77e-05	0.000443	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Timolol—glaucoma	5.75e-05	0.000441	CcSEcCtD
L-DOPA—Fatigue—Timolol—glaucoma	5.75e-05	0.000441	CcSEcCtD
L-DOPA—Pain—Timolol—glaucoma	5.7e-05	0.000437	CcSEcCtD
L-DOPA—Diarrhoea—Betaxolol—glaucoma	5.58e-05	0.000428	CcSEcCtD
L-DOPA—Nausea—Clonidine—glaucoma	5.57e-05	0.000427	CcSEcCtD
L-DOPA—Feeling abnormal—Timolol—glaucoma	5.49e-05	0.000421	CcSEcCtD
L-DOPA—Gastrointestinal pain—Timolol—glaucoma	5.45e-05	0.000418	CcSEcCtD
L-DOPA—Dizziness—Betaxolol—glaucoma	5.4e-05	0.000414	CcSEcCtD
L-DOPA—Urticaria—Timolol—glaucoma	5.29e-05	0.000406	CcSEcCtD
L-DOPA—Abdominal pain—Timolol—glaucoma	5.27e-05	0.000404	CcSEcCtD
L-DOPA—DRD4—GPCR downstream signaling—OPN4—glaucoma	5.23e-05	0.00159	CbGpPWpGaD
L-DOPA—DDC—Metabolism—CTSA—glaucoma	5.21e-05	0.00159	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—NTRK1—glaucoma	5.21e-05	0.00159	CbGpPWpGaD
L-DOPA—Vomiting—Betaxolol—glaucoma	5.19e-05	0.000398	CcSEcCtD
L-DOPA—Rash—Betaxolol—glaucoma	5.14e-05	0.000395	CcSEcCtD
L-DOPA—Dermatitis—Betaxolol—glaucoma	5.14e-05	0.000394	CcSEcCtD
L-DOPA—Headache—Betaxolol—glaucoma	5.11e-05	0.000392	CcSEcCtD
L-DOPA—SLC7A5—Hemostasis—MMP1—glaucoma	5.02e-05	0.00153	CbGpPWpGaD
L-DOPA—DRD5—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	4.93e-05	0.0015	CbGpPWpGaD
L-DOPA—DDC—Metabolism—CA2—glaucoma	4.92e-05	0.0015	CbGpPWpGaD
L-DOPA—Hypersensitivity—Timolol—glaucoma	4.91e-05	0.000377	CcSEcCtD
L-DOPA—Nausea—Betaxolol—glaucoma	4.85e-05	0.000372	CcSEcCtD
L-DOPA—SLC7A5—Hemostasis—CAV1—glaucoma	4.81e-05	0.00147	CbGpPWpGaD
L-DOPA—DDC—SIDS Susceptibility Pathways—VEGFA—glaucoma	4.8e-05	0.00147	CbGpPWpGaD
L-DOPA—Asthenia—Timolol—glaucoma	4.78e-05	0.000367	CcSEcCtD
L-DOPA—SLC15A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.76e-05	0.00145	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—OPN4—glaucoma	4.75e-05	0.00145	CbGpPWpGaD
L-DOPA—Pruritus—Timolol—glaucoma	4.72e-05	0.000362	CcSEcCtD
L-DOPA—DRD4—GPCR downstream signaling—PTGFR—glaucoma	4.71e-05	0.00144	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—OPN4—glaucoma	4.71e-05	0.00144	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—OPN4—glaucoma	4.64e-05	0.00142	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—FAS—glaucoma	4.59e-05	0.0014	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—FN1—glaucoma	4.58e-05	0.0014	CbGpPWpGaD
L-DOPA—Diarrhoea—Timolol—glaucoma	4.56e-05	0.00035	CcSEcCtD
L-DOPA—PSIP1—Disease—MTHFR—glaucoma	4.44e-05	0.00135	CbGpPWpGaD
L-DOPA—Dizziness—Timolol—glaucoma	4.41e-05	0.000338	CcSEcCtD
L-DOPA—DRD5—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	4.3e-05	0.00131	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—PTGFR—glaucoma	4.27e-05	0.0013	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—OPN4—glaucoma	4.27e-05	0.0013	CbGpPWpGaD
L-DOPA—Vomiting—Timolol—glaucoma	4.24e-05	0.000325	CcSEcCtD
L-DOPA—DRD1—GPCR downstream signaling—PTGFR—glaucoma	4.24e-05	0.00129	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—OPN4—glaucoma	4.22e-05	0.00129	CbGpPWpGaD
L-DOPA—Rash—Timolol—glaucoma	4.2e-05	0.000322	CcSEcCtD
L-DOPA—DRD4—GPCR ligand binding—SMO—glaucoma	4.2e-05	0.00128	CbGpPWpGaD
L-DOPA—Dermatitis—Timolol—glaucoma	4.2e-05	0.000322	CcSEcCtD
L-DOPA—DRD2—Circadian rythm related genes—NGFR—glaucoma	4.19e-05	0.00128	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—PTGFR—glaucoma	4.18e-05	0.00128	CbGpPWpGaD
L-DOPA—Headache—Timolol—glaucoma	4.18e-05	0.00032	CcSEcCtD
L-DOPA—SLC7A8—Hemostasis—NOS3—glaucoma	4.17e-05	0.00127	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—FAS—glaucoma	4.13e-05	0.00126	CbGpPWpGaD
L-DOPA—PSIP1—Disease—APOE—glaucoma	4.13e-05	0.00126	CbGpPWpGaD
L-DOPA—DDC—SIDS Susceptibility Pathways—TNF—glaucoma	4.12e-05	0.00126	CbGpPWpGaD
L-DOPA—PSIP1—Disease—CAV1—glaucoma	4.09e-05	0.00125	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—FAS—glaucoma	4.08e-05	0.00124	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—LRP12—glaucoma	4.05e-05	0.00123	CbGpPWpGaD
L-DOPA—DRD4—G alpha (i) signalling events—C3—glaucoma	4e-05	0.00122	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—NTRK1—glaucoma	3.98e-05	0.00122	CbGpPWpGaD
L-DOPA—Nausea—Timolol—glaucoma	3.96e-05	0.000304	CcSEcCtD
L-DOPA—DRD1—Signaling by GPCR—PTGFR—glaucoma	3.85e-05	0.00117	CbGpPWpGaD
L-DOPA—PSIP1—Disease—BAD—glaucoma	3.85e-05	0.00117	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—OPN4—glaucoma	3.8e-05	0.00116	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—PTGFR—glaucoma	3.8e-05	0.00116	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—SMO—glaucoma	3.78e-05	0.00115	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—EDN1—glaucoma	3.75e-05	0.00114	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—SMO—glaucoma	3.73e-05	0.00114	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—LRP12—glaucoma	3.64e-05	0.00111	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—NOS3—glaucoma	3.64e-05	0.00111	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.64e-05	0.00111	CbGpPWpGaD
L-DOPA—CYP2D6—Biological oxidations—GSTT1—glaucoma	3.61e-05	0.0011	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—LRP12—glaucoma	3.59e-05	0.0011	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—OPN4—glaucoma	3.55e-05	0.00108	CbGpPWpGaD
L-DOPA—DRD3—G alpha (i) signalling events—C3—glaucoma	3.55e-05	0.00108	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HEYL—glaucoma	3.53e-05	0.00108	CbGpPWpGaD
L-DOPA—DDC—Metabolism—TXN—glaucoma	3.46e-05	0.00106	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PTGFR—glaucoma	3.42e-05	0.00104	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—C3—glaucoma	3.28e-05	0.001	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.27e-05	0.000999	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.23e-05	0.000985	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—OPN4—glaucoma	3.23e-05	0.000984	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—PTGFR—glaucoma	3.2e-05	0.000976	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	3.18e-05	0.000969	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—FAS—glaucoma	3.12e-05	0.000952	CbGpPWpGaD
L-DOPA—PSIP1—Disease—NOS3—glaucoma	3.09e-05	0.000944	CbGpPWpGaD
L-DOPA—SLC7A8—Hemostasis—VEGFA—glaucoma	3e-05	0.000916	CbGpPWpGaD
L-DOPA—DDC—Circadian rythm related genes—TP53—glaucoma	2.96e-05	0.000904	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—SMO—glaucoma	2.92e-05	0.000891	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—PTGFR—glaucoma	2.91e-05	0.000886	CbGpPWpGaD
L-DOPA—CYP2D6—Biological oxidations—CYP1B1—glaucoma	2.88e-05	0.000878	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.86e-05	0.000872	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—SMO—glaucoma	2.85e-05	0.000871	CbGpPWpGaD
L-DOPA—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	2.84e-05	0.000866	CbGpPWpGaD
L-DOPA—PSIP1—Disease—PTGS2—glaucoma	2.83e-05	0.000863	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.82e-05	0.000861	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—OPN4—glaucoma	2.8e-05	0.000856	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—EDN1—glaucoma	2.77e-05	0.000845	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—LRP12—glaucoma	2.75e-05	0.000839	CbGpPWpGaD
L-DOPA—DRD2—G alpha (i) signalling events—C3—glaucoma	2.72e-05	0.000828	CbGpPWpGaD
L-DOPA—DDC—Metabolism—GSTT1—glaucoma	2.69e-05	0.000819	CbGpPWpGaD
L-DOPA—PSIP1—Disease—CDKN1B—glaucoma	2.68e-05	0.000817	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—RPTOR—glaucoma	2.68e-05	0.000817	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—VEGFA—glaucoma	2.62e-05	0.000799	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HEYL—glaucoma	2.61e-05	0.000795	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NCK2—glaucoma	2.59e-05	0.000791	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—NARFL—glaucoma	2.53e-05	0.000772	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CA5A—glaucoma	2.53e-05	0.000772	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PTGFR—glaucoma	2.53e-05	0.00077	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—OPN4—glaucoma	2.52e-05	0.00077	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—EDN1—glaucoma	2.49e-05	0.00076	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—OPN4—glaucoma	2.49e-05	0.00076	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.47e-05	0.000754	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—EDN1—glaucoma	2.46e-05	0.00075	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—C3—glaucoma	2.42e-05	0.000738	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HEYL—glaucoma	2.35e-05	0.000716	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HEYL—glaucoma	2.32e-05	0.000706	CbGpPWpGaD
L-DOPA—CYP2D6—Biological oxidations—GSTM1—glaucoma	2.3e-05	0.000702	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PTGFR—glaucoma	2.27e-05	0.000693	CbGpPWpGaD
L-DOPA—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	2.27e-05	0.000692	CbGpPWpGaD
L-DOPA—SLC7A8—Hemostasis—TP53—glaucoma	2.27e-05	0.000692	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PTGFR—glaucoma	2.24e-05	0.000684	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HDAC9—glaucoma	2.2e-05	0.000673	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—C3—glaucoma	2.18e-05	0.000664	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.16e-05	0.000659	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—SMO—glaucoma	2.16e-05	0.000658	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—C3—glaucoma	2.15e-05	0.000655	CbGpPWpGaD
L-DOPA—DDC—Metabolism—CYP1B1—glaucoma	2.14e-05	0.000653	CbGpPWpGaD
L-DOPA—DDC—Metabolism—ABCA1—glaucoma	2.14e-05	0.000653	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—EDN1—glaucoma	2.12e-05	0.000647	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—TP53—glaucoma	1.98e-05	0.000604	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—RPTOR—glaucoma	1.98e-05	0.000603	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—SMO—glaucoma	1.94e-05	0.000592	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—EDN1—glaucoma	1.93e-05	0.000587	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—SMO—glaucoma	1.91e-05	0.000584	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NCK2—glaucoma	1.91e-05	0.000584	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—OPN4—glaucoma	1.91e-05	0.000582	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—EDN1—glaucoma	1.88e-05	0.000574	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—C3—glaucoma	1.85e-05	0.000565	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—RPTOR—glaucoma	1.78e-05	0.000543	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HEYL—glaucoma	1.77e-05	0.000541	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—RPTOR—glaucoma	1.76e-05	0.000535	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—SMO—glaucoma	1.73e-05	0.000526	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NCK2—glaucoma	1.72e-05	0.000526	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—TP53—glaucoma	1.72e-05	0.000524	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PTGFR—glaucoma	1.72e-05	0.000524	CbGpPWpGaD
L-DOPA—DDC—Metabolism—GSTM1—glaucoma	1.71e-05	0.000522	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NCK2—glaucoma	1.7e-05	0.000519	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—C3—glaucoma	1.68e-05	0.000513	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—C3—glaucoma	1.64e-05	0.000502	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HDAC9—glaucoma	1.63e-05	0.000496	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NTRK2—glaucoma	1.58e-05	0.000481	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—EDN1—glaucoma	1.56e-05	0.000477	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—TP53—glaucoma	1.55e-05	0.000472	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—TP53—glaucoma	1.53e-05	0.000466	CbGpPWpGaD
L-DOPA—DDC—Metabolism—MTHFR—glaucoma	1.51e-05	0.000461	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—SMO—glaucoma	1.47e-05	0.000447	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HDAC9—glaucoma	1.46e-05	0.000447	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HDAC9—glaucoma	1.45e-05	0.000441	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—EDN1—glaucoma	1.42e-05	0.000434	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—EDN1—glaucoma	1.41e-05	0.00043	CbGpPWpGaD
L-DOPA—DDC—Metabolism—APOE—glaucoma	1.41e-05	0.000429	CbGpPWpGaD
L-DOPA—DDC—Metabolism—CAV1—glaucoma	1.39e-05	0.000426	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—EDN1—glaucoma	1.39e-05	0.000424	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—C3—glaucoma	1.37e-05	0.000417	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NGFR—glaucoma	1.35e-05	0.000413	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—RPTOR—glaucoma	1.34e-05	0.00041	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NCK2—glaucoma	1.3e-05	0.000397	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NTRK1—glaucoma	1.29e-05	0.000392	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—EDN1—glaucoma	1.28e-05	0.00039	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—SMO—glaucoma	1.27e-05	0.000388	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—EDN1—glaucoma	1.26e-05	0.000385	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—C3—glaucoma	1.24e-05	0.000379	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CA1—glaucoma	1.24e-05	0.000377	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—C3—glaucoma	1.23e-05	0.000375	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—C3—glaucoma	1.21e-05	0.00037	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CTSA—glaucoma	1.2e-05	0.000365	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CDKN2B—glaucoma	1.19e-05	0.000362	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—TP53—glaucoma	1.17e-05	0.000356	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NTRK2—glaucoma	1.16e-05	0.000355	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—SMO—glaucoma	1.15e-05	0.00035	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—EDN1—glaucoma	1.14e-05	0.000347	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—SMO—glaucoma	1.13e-05	0.000345	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CA2—glaucoma	1.13e-05	0.000345	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—C3—glaucoma	1.12e-05	0.000341	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HDAC9—glaucoma	1.11e-05	0.000337	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—C3—glaucoma	1.1e-05	0.000336	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—EDN1—glaucoma	1.06e-05	0.000324	CbGpPWpGaD
L-DOPA—DDC—Metabolism—NOS3—glaucoma	1.05e-05	0.000322	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NTRK2—glaucoma	1.05e-05	0.00032	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NGF—glaucoma	1.05e-05	0.000319	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NTRK2—glaucoma	1.03e-05	0.000316	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NGFR—glaucoma	9.99e-06	0.000305	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—C3—glaucoma	9.94e-06	0.000303	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—EDN1—glaucoma	9.66e-06	0.000295	CbGpPWpGaD
L-DOPA—DDC—Metabolism—PTGS2—glaucoma	9.65e-06	0.000294	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NTRK1—glaucoma	9.49e-06	0.00029	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—C3—glaucoma	9.29e-06	0.000283	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—APOE—glaucoma	9.25e-06	0.000282	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CAV1—glaucoma	9.17e-06	0.00028	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NGFR—glaucoma	8.99e-06	0.000274	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NGFR—glaucoma	8.88e-06	0.000271	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CDKN2B—glaucoma	8.75e-06	0.000267	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—FN1—glaucoma	8.72e-06	0.000266	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SMO—glaucoma	8.65e-06	0.000264	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—BAD—glaucoma	8.62e-06	0.000263	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NTRK1—glaucoma	8.55e-06	0.000261	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—C3—glaucoma	8.44e-06	0.000257	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NTRK1—glaucoma	8.43e-06	0.000257	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—EDN1—glaucoma	8.39e-06	0.000256	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—TXN—glaucoma	7.97e-06	0.000243	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NTRK2—glaucoma	7.92e-06	0.000241	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CDKN2B—glaucoma	7.88e-06	0.00024	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CDKN2B—glaucoma	7.77e-06	0.000237	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NGF—glaucoma	7.71e-06	0.000235	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—EDN1—glaucoma	7.56e-06	0.000231	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—EDN1—glaucoma	7.46e-06	0.000227	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—C3—glaucoma	7.33e-06	0.000224	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NGF—glaucoma	6.94e-06	0.000212	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NOS3—glaucoma	6.93e-06	0.000211	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NGF—glaucoma	6.85e-06	0.000209	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—APOE—glaucoma	6.83e-06	0.000208	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NGFR—glaucoma	6.79e-06	0.000207	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CAV1—glaucoma	6.76e-06	0.000206	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—C3—glaucoma	6.6e-06	0.000201	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—C3—glaucoma	6.51e-06	0.000199	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NTRK1—glaucoma	6.45e-06	0.000197	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—FN1—glaucoma	6.44e-06	0.000196	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—BAD—glaucoma	6.36e-06	0.000194	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GSTT1—glaucoma	6.18e-06	0.000188	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—APOE—glaucoma	6.15e-06	0.000187	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CAV1—glaucoma	6.09e-06	0.000186	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—APOE—glaucoma	6.06e-06	0.000185	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CAV1—glaucoma	6.01e-06	0.000183	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CDKN1B—glaucoma	6e-06	0.000183	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CDKN2B—glaucoma	5.95e-06	0.000181	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—FN1—glaucoma	5.8e-06	0.000177	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—BAD—glaucoma	5.73e-06	0.000175	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—FN1—glaucoma	5.72e-06	0.000174	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—EDN1—glaucoma	5.71e-06	0.000174	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—BAD—glaucoma	5.65e-06	0.000172	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MMP9—glaucoma	5.56e-06	0.00017	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NGF—glaucoma	5.24e-06	0.00016	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NOS3—glaucoma	5.11e-06	0.000156	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—VEGFA—glaucoma	4.99e-06	0.000152	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—C3—glaucoma	4.98e-06	0.000152	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ABCA1—glaucoma	4.92e-06	0.00015	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CYP1B1—glaucoma	4.92e-06	0.00015	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—APOE—glaucoma	4.64e-06	0.000142	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NOS3—glaucoma	4.6e-06	0.00014	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CAV1—glaucoma	4.6e-06	0.00014	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NOS3—glaucoma	4.54e-06	0.000139	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CDKN1B—glaucoma	4.43e-06	0.000135	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—FN1—glaucoma	4.38e-06	0.000133	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—BAD—glaucoma	4.32e-06	0.000132	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MMP9—glaucoma	4.1e-06	0.000125	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CDKN1B—glaucoma	3.99e-06	0.000122	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CDKN1B—glaucoma	3.94e-06	0.00012	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GSTM1—glaucoma	3.93e-06	0.00012	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TP53—glaucoma	3.77e-06	0.000115	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MMP9—glaucoma	3.69e-06	0.000113	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—VEGFA—glaucoma	3.69e-06	0.000112	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MMP9—glaucoma	3.65e-06	0.000111	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—MTHFR—glaucoma	3.48e-06	0.000106	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NOS3—glaucoma	3.48e-06	0.000106	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—VEGFA—glaucoma	3.32e-06	0.000101	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—VEGFA—glaucoma	3.27e-06	9.99e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—APOE—glaucoma	3.24e-06	9.88e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CAV1—glaucoma	3.21e-06	9.78e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CDKN1B—glaucoma	3.01e-06	9.19e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MMP9—glaucoma	2.79e-06	8.51e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TP53—glaucoma	2.78e-06	8.49e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TP53—glaucoma	2.51e-06	7.65e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—VEGFA—glaucoma	2.5e-06	7.64e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TP53—glaucoma	2.47e-06	7.54e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—NOS3—glaucoma	2.43e-06	7.4e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PTGS2—glaucoma	2.22e-06	6.77e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TP53—glaucoma	1.89e-06	5.77e-05	CbGpPWpGaD
